Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.03	19.31	20.21	18.6	36.89
Short-Term Investments	0.04	-	-	-	-
Trading Asset Securities	-	0.04	0.08	0.04	0.04
Cash & Short-Term Investments	7.07	19.35	20.29	18.64	36.93
Cash Growth	-63.48%	-4.63%	8.83%	-49.53%	44.22%
Accounts Receivable	127.26	117.68	120.71	107.37	87.63
Other Receivables	12.24	8.67	6.83	2.25	1.98
Receivables	139.5	126.35	127.54	109.62	89.61
Inventory	82.48	96.6	92.2	89.61	97.85
Prepaid Expenses	-	1.94	1.83	1.42	0.71
Other Current Assets	-	7.09	1.28	2.37	2.25
Total Current Assets	229.05	251.33	243.14	221.66	227.35
Property, Plant & Equipment	140.07	154.62	163.21	177	181.82
Long-Term Investments	1.18	1.17	-	-	1.84
Goodwill	35.14	35.14	15.18	-	-
Other Intangible Assets	25.7	31.66	20.67	32.97	4.18
Long-Term Deferred Tax Assets	16.07	10.79	6.22	5.46	4.5
Other Long-Term Assets	-	0.01	0.01	0.01	0.01
Total Assets	447.22	484.72	448.42	437.09	419.69
Accounts Payable	96.57	78.89	81.21	57.44	59.89
Accrued Expenses	-	23.95	17.05	13.61	12.96
Short-Term Debt	29.55	3.12	-	0.01	5
Current Portion of Long-Term Debt	-	26.94	30.9	18.96	22.06
Current Portion of Leases	7.29	6.9	5.59	5.03	4.82
Current Income Taxes Payable	0.35	1.56	0.76	0.26	0.96
Current Unearned Revenue	-	0.13	0.1	0.25	0.88
Other Current Liabilities	24.3	2.31	3.44	3.04	1.7
Total Current Liabilities	158.04	143.79	139.03	98.61	108.26
Long-Term Debt	63.62	110.09	91.66	101.23	90.86
Long-Term Leases	33.7	38.76	37.55	40.6	43.6
Long-Term Deferred Tax Liabilities	-	6.03	2.75	3.16	-
Other Long-Term Liabilities	19.3	20.74	6.49	11.21	2
Total Liabilities	285.24	329.14	286.34	264.03	254.1
Common Stock	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61
Retained Earnings	21.19	14.67	21.35	32.73	25.69
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51
Comprehensive Income & Other	0.99	1.12	0.93	0.54	0.09
Total Common Equity	161.93	155.54	162.03	173.01	165.53
Minority Interest	0.05	0.05	0.05	0.05	0.06
Shareholders' Equity	161.98	155.59	162.08	173.07	165.59
Total Liabilities & Equity	447.22	484.72	448.42	437.09	419.69
Total Debt	134.16	185.8	165.7	165.82	166.34
Net Cash (Debt)	-127.09	-166.45	-145.41	-147.18	-129.41
Net Cash Per Share	-11.06	-14.58	-12.74	-12.89	-11.34
Filing Date Shares Outstanding	12.75	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	12.75	11.41	11.41	11.41	11.41
Working Capital	71.01	107.54	104.11	123.05	119.09
Book Value Per Share	12.70	13.63	14.19	15.16	14.50
Tangible Book Value	101.09	88.73	126.18	140.05	161.35
Tangible Book Value Per Share	7.93	7.77	11.05	12.27	14.14
Land	-	1.89	2.07	2.07	2.07
Buildings	-	117.94	124.71	122.66	119.21
Machinery	-	121.03	112.99	109.84	106.6
Leasehold Improvements	-	61.15	58.28	57.23	54.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.